相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?
Geertruida E. Bekkering et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma
Gretchen M. Kreizenbeck et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma
Anne H. Vaisanen et al.
HUMAN PATHOLOGY (2008)
Bim expression is reduced in human cutaneous melanomas
Derek L. Dai et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy
R. A. Pearl et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2008)
Mortality impact of less-than-standard therapy in older breast cancer patients
Marianne Ulcickas Yood et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Organ selectivity in metastasis: regulation by chemokines and their receptors
Adit Ben-Baruch
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Su Young Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
HSP90 as a marker of progression in melanoma
M. M. McCarthy et al.
ANNALS OF ONCOLOGY (2008)
Osteopontin as a molecular prognostic marker for melanoma
Javier Rangel et al.
CANCER (2008)
DNA damage signalling guards against activated oncogenes and tumour progression
J. Bartek et al.
ONCOGENE (2007)
Involvement of E-cadherin, β-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma
M. G. Tucci et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Chemokines in tumor angiogenesis and metastasis
Seema Singh et al.
CANCER AND METASTASIS REVIEWS (2007)
DNA microarray analyses of melanoma gene expression: a decade in the mines
Keith S. Hoek
PIGMENT CELL RESEARCH (2007)
Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression
Janine G. Einspahr et al.
CANCER (2007)
EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis
Zsuzsa Rakosy et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Opposing roles of murine Duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth
Linda W. Horton et al.
CANCER RESEARCH (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Relocalized p27KiP1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma
Catherine Denicourt et al.
CANCER RESEARCH (2007)
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis
Nancy Gavert et al.
CANCER RESEARCH (2007)
Decreased expression of retinoid receptors in melanoma: Entailment in tumorigenesis and prognosis
Nitin Chakravarti et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic significance of nuclear ING3 expression in human cutaneous melanoma
Yemin Wang et al.
CLINICAL CANCER RESEARCH (2007)
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition
Cristina R. Antonescu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
R. O. Pritchard-Jones et al.
BRITISH JOURNAL OF CANCER (2007)
Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma
F. Piras et al.
HISTOPATHOLOGY (2007)
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
C. Monteagudo et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
PCNA, the maestro of the replication fork
George-Lucian Moldovan et al.
CELL (2007)
Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma
Hannes Seidl et al.
HUMAN PATHOLOGY (2007)
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis
Soledad R. Alonso et al.
CANCER RESEARCH (2007)
Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma
Liqing Zhuang et al.
MODERN PATHOLOGY (2007)
c-Met is a potentially new therapeutic target for treatment of human melanoma
Neelu Puri et al.
CLINICAL CANCER RESEARCH (2007)
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas
Phyllis A. Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma
K. A. Giehl et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions
Rajendra S. Singh et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis
Bonnie E. Gould Rothberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Hypothesis testing - Proportions
Kimberlee Gauvreau
CIRCULATION (2006)
The role of N-cadherin, MCAM and β3 integrin in melanoma progression, proliferation, migration and invasion
Kelly Watson-Hurst et al.
CANCER BIOLOGY & THERAPY (2006)
Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
Javier Rangel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study
Emanuele Crocetti et al.
MELANOMA RESEARCH (2006)
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN
Leisl Packer et al.
CARCINOGENESIS (2006)
Acral lentiginous melanoma:: a clinicoprognostic study of 126 cases
A. Phan et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Tumor iNOS predicts poor survival for stage III melanoma patients
Suhendan Ekmekcioglu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Nuclear ING2 expression is reduced in human cutaneous melanomas
F. Lu et al.
BRITISH JOURNAL OF CANCER (2006)
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
S. Streit et al.
BRITISH JOURNAL OF CANCER (2006)
Expression of tumor necrosis factor-related apoptosis-inducing ligand receptors 1 and 2 in melanoma
Mary M. McCarthy et al.
CLINICAL CANCER RESEARCH (2006)
Novel biomarkers in malignant melanoma
AK Bosserhoff
CLINICA CHIMICA ACTA (2006)
Gender-related differences in outcome for melanoma patients
CR Scoggins et al.
ANNALS OF SURGERY (2006)
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas
Michael D. Onken et al.
CANCER RESEARCH (2006)
p16 expression in primary malignant melanoma is associated with prognosis and lymph node status
D Mihic-Probst et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gene expression profiling of primary cutaneous melanoma and clinical outcome
VR Winnepenninckx et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Strategies for the development of more effective adjuvant therapy of melanoma: Current and future explorations of antibodies, cytokines, vaccines, and combinations
JM Kirkwood et al.
CLINICAL CANCER RESEARCH (2006)
Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec™)
D Ivan et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2006)
The correlation of angiogenesis with metastasis in primary cutaneous melanoma:: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor
C Demirkesen et al.
PATHOLOGY (2006)
Expression pattern of osteopontin in endometrial carcinoma:: Correlation with expression of the adhesion molecule CEACAM1
J Briese et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients
G Weinlich et al.
BRITISH JOURNAL OF CANCER (2006)
CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: Assessment by the use of tissue microarray
MD Pacifico et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Importance of P-cadherin, β-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma
IM Bachmann et al.
CLINICAL CANCER RESEARCH (2005)
Clinical significance of CXCR3 and CXCR4 expression in primary melanoma
MI Longo-Imedio et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Automated quantitative analysis of activator protein-2α subcellular expression in melanoma tissue microarrays correlates with survival prediction
AJ Berger et al.
CANCER RESEARCH (2005)
Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma
L Zhuang et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Strong expression of IDI protein is associated with decreased survival, increased expression of ephrin-Al/EPHA2, and reduced thrombospondin-I in malignant melanoma
O Straume et al.
BRITISH JOURNAL OF CANCER (2005)
Expression of activated Akt and PTEN in malignant melanomas - Relationship with clinical outcome
A Slipicevic et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up
MD Pacifico et al.
MELANOMA RESEARCH (2005)
Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma
S Ilmonen et al.
MELANOMA RESEARCH (2005)
Identification of P-cadherin in primary melanoma using a tissue microarrayer - Prognostic implications in a patient cohort with long-term follow up
MD Pacifico et al.
ANNALS OF PLASTIC SURGERY (2005)
Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region
S Staibano et al.
HUMAN PATHOLOGY (2005)
Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma
MH Soltani et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Osteopontin expression correlates with melanoma invasion
YW Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
S Scala et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases
DL Dai et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PUMA expression is significantly reduced in human cutaneous melanomas
AM Karst et al.
ONCOGENE (2005)
VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas
AM Pisacane et al.
MELANOMA RESEARCH (2005)
Development of a tissue array for primary melanoma with long-term follow-up: Discovering melanoma cell adhesion molecule as an important prognostic marker
MD Pacifico et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions
D Stefanou et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2004)
Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma
A Potti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Tenascin-C in primary malignant melanoma of the skin
S Ilmonen et al.
HISTOPATHOLOGY (2004)
Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American joint committee on cancer staging
PA Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Expression of activated TrkA protein in melanocytic tumors -: Relationship to cell proliferation and clinical outcome
VA Florenes et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
K Andersen et al.
MODERN PATHOLOGY (2004)
Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma
LP Bron et al.
PATHOLOGY (2004)
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome
AJ Berger et al.
CANCER RESEARCH (2004)
Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours
M Korabiowska et al.
MODERN PATHOLOGY (2004)
Tree-based multivariate regression and density estimation with right-censored data
AM Molinaro et al.
JOURNAL OF MULTIVARIATE ANALYSIS (2004)
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma
KA DiVito et al.
CANCER RESEARCH (2004)
High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma
GFL Hofbauer et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Progression in cutaneous malignant melanoma is associated with distinct expression profiles - A tissue microarray-based study
SR Alonso et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis
EE Torlakovic et al.
MODERN PATHOLOGY (2004)
Chemokine receptors and melanoma metastasis
T Murakami et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2004)
Skp2 and p27kip1 expression in melanocytic nevi and melanoma:: an inverse relationship
Q Li et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2004)
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer staging system: An analysis of the German Central Malignant Melanoma Registry
TK Eigentler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
Immunohistochemistry in melanocytic proliferative lesions
NJW de Wit et al.
HISTOPATHOLOGY (2004)
Expression of AP-2α, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin.: A possible role for caspases in melanoma progression?
C Woenckhaus et al.
JOURNAL OF PATHOLOGY (2003)
Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array
SS Shen et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2003)
Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin
A Giatromanolaki et al.
MELANOMA RESEARCH (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients
G Weinlich et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Immunologic escape and angiogenesis in human malignant melanoma
P Redondo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
The INK4a/ARF locus and melanoma
NE Sharpless et al.
ONCOGENE (2003)
Expression of neurotrophin receptor Trk-C in nevi and melanomas
XW Xu et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2003)
Tissue microarray-based analysis shows phospho-β-catenin expression in malignant melanoma is associated with poor outcome
E Kielhorn et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype
ML Varney et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas
J Cruz et al.
ONCOLOGY (2003)
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions
O Simonetti et al.
CANCER (2002)
Matricellular proteins: extracellular modulators of cell function
P Bornstein et al.
CURRENT OPINION IN CELL BIOLOGY (2002)
Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma
A Thies et al.
EUROPEAN JOURNAL OF CANCER (2002)
Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma
C Hazan et al.
CANCER (2002)
CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease
A Thies et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Differential expression of DNA nonhomologous end-joining proteins Ku70 and Ku80 in melanoma progression
M Korabiowska et al.
MODERN PATHOLOGY (2002)
Overexpression of HER-2 in thick melanoma
P Eliopoulos et al.
MELANOMA RESEARCH (2002)
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma
J Nikkola et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Immunohistochemically detectable Bcl-2 expression in metastatic melanoma: Association with survival and treatment response
T Vlaykova et al.
ONCOLOGY (2002)
Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression
O Straume et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
E Steels et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
CM Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Prognostic immunohistochemical markers of primary human melanomas
H Ostmeier et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas
O Straume et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Expression of neurotrophins and their receptors in pigment cell lesions of the skin
PF Innominato et al.
JOURNAL OF PATHOLOGY (2001)
Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma
N Ricaniadis et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: Different correlation according to thickness
S Moretti et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma
A Baldi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Downregulation of the retinoblastoma gene expression in the progression of malignant melanoma
M Korabiowska et al.
PATHOBIOLOGY (2001)
Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma
R Henrique et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
High tPA-expression in primary melanoma of the limb correlates with good prognosis
CM Ferrier et al.
BRITISH JOURNAL OF CANCER (2000)
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner et al.
NATURE (2000)
Topoisomerase II-alpha expression in melanocytic nevi and malignant melanoma
XC Mu et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2000)
Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma
JM Karjalainen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
